Ella A Kasanga

2016- Institute for Healthy Aging University of North Texas Health Science Center at Fort Worth 
Parkinson's and aging
"Ella Kasanga"
Mean distance: (not calculated yet)
BETA: Related publications


You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect.

Kasanga EA, Owens CL, Cantu MA, et al. (2019) GFR-α1 expression in substantia nigra increases bilaterally following unilateral striatal GDNF in aged rats and attenuates nigral tyrosine hydroxylase loss following 6-OHDA nigrostriatal lesion. Acs Chemical Neuroscience
Churchill MJ, Cantu MA, Kasanga EA, et al. (2019) Glatiramer acetate reverses motor dysfunction and the decrease in tyrosine hydroxylase levels in a mouse model of Parkinson's disease. Neuroscience
Arnold JC, Cantu MA, Kasanga EA, et al. (2017) Aging-related limit of exercise efficacy on motor decline. Plos One. 12: e0188538
Salvatore MF, Terrebonne J, Cantu MA, et al. (2017) Dissociation of striatal dopamine and tyrosine hydroxylase expression from aging-related motor decline: evidence from calorie restriction intervention. The Journals of Gerontology. Series a, Biological Sciences and Medical Sciences
Chotibut T, Meadows S, Kasanga EA, et al. (2017) Ceftriaxone reduces L-dopa-induced dyskinesia severity in 6-hydroxydopamine parkinson's disease model. Movement Disorders : Official Journal of the Movement Disorder Society
See more...